Stay updated on Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.

Latest updates to the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision updates the software version from v3.2.0 to v3.3.2 and does not affect study content or displayed information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page no longer displays the government funding status notice at the top, a general site-wide notice that does not affect the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo additions or deletions were detected. The page content and structure appear unchanged.SummaryDifference0.4%

- Check62 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check69 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Lung cancer, expanding the page to cover genetic aspects of lung cancer. No deletions were reported.SummaryDifference0.2%

Stay in the know with updates to Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.